The French National Medicines Safety Agency (ANSM) confirmed the exclusion of flowers from their medical cannabis framework, sparking outrage due to the lack of alternatives for patients and disruption to businesses. This decision follows a last-minute amendment but will impact patients and businesses as the long-awaited medical cannabis generalisation in France is rolled out.
Read the full story here
Written by: Ben Stevens
Published on March 14, 2024 at 11:21AM
Source: Business of Cannabis (opens in new tab)